Le Lézard
Classified in: Covid-19 virus
Subject: Product/Service

AR Tech Announces U.S. Patent Issued to Dr. Mark Comunale for Patient Isolation Transportation Unit- PITU

PITU, the invention created by Dr. Mark Comunale, head of Anesthesiology at Arrowhead Regional Medical Center, addresses many of the issues we are facing over the COVID-19 virus. This negative pressure enclosure isolates COVID-19 patients, creates a barrier between them and medical professionals treating them, and can even allow family members to visit them.

Dr. Comunale has received U.S. Patent No. 10,716,725, after having previously received the FDA's Emergency Use Authorization in late June of this year. In both the analyses of the U.S. Patent application and the FDA's EUA, PITU was found to have no equal in the market place in addressing the needs to both isolate the patients and allow access to them. PITU fits on standard medical gurneys and can be used to both transport and temporarily house patients at a time when facilities are overwhelmed in their ICU and ER's due to COVID-19.

Because it is spacious, PITU also allows the patient the ability to sit up, eat, read and even watch TV through its transparent walls.

Dr. Comunale, and AR Tech, an aerospace and medical equipment manufacturer in Fontana, California, have teamed up to produce and sell PITU to medical facilities and believe it can serve wherever large crowds of people gather, including amusement parks, festivals, cruise ships, and so on.

About AR Tech

AR Tech is a subsidiary of A&R Tarpaulins Inc. which is the parent company of AR Industries and provides products and services for medical companies, flight hardware and ground support to various aerospace companies providing satellite launches, architectural products and services for homes and businesses, and industrial products for the transportation industry. For more information contact A&R at 909-829-4444 or visit http://www.artarpaulins.com.

About Arrowhead Regional Medical Center

For information about ARMC, visit www.arrowheadregional.org. Follow ARMC on Twitter at @ArrowheadRMC for important announcements and updates, and on Facebook at www.facebook.com/arrowheadregional.

These press releases may also interest you

at 12:05
The Prime Minister, Justin Trudeau, today issued the following statement on Gender Equality Week: "Today, we begin Canada's Gender Equality Week. This week is an opportunity to celebrate the accomplishments we have made in advancing gender equality,...

at 12:00
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 142,774 cases of COVID-19 in Canada, including 9,211 deaths. 87% of people have now recovered....

at 11:17
On the eve of a new parliamentary session in the House of Commons, the Coalition for Culture and Media (CCM) is asking the Federal government to table, legislative measures in the coming weeks, ensuring the application of Canadian regulations to all...

at 11:00
The most recent data on the evolution of COVID-19 in Québec show 462 new cases, bringing the total number of people infected to 67,542. Also, 1 new death has occurred in the last 24 hours, to which are added 4 deaths which have occurred between...

at 11:00
The Auden Living group of modern housing complexes developed by DMG Investments has announced a new discount program for frontline workers. Through the housing company's Our Heroes Program and their Military and Veterans Program, their housing...

at 10:25
Merck , known as MSD outside the United States and Canada, today announced the presentation of new data for three investigational medicines in Merck's diverse and expansive oncology pipeline: vibostolimab (MK-7684), an anti-TIGIT therapy; MK-4830, a...

News published on 4 august 2020 at 18:40 and distributed by: